Immuron (IMRN) EBIT (2016 - 2024)
Immuron has reported EBIT over the past 9 years, most recently at $1660259127.7 billion for Q4 2024.
- For Q4 2024, EBIT rose 1.2625362290076214e+16% year-over-year to $1660259127.7 billion; the TTM value through Dec 2024 reached $1660259127.7 billion, up 12517416746.7%, while the annual FY2025 figure was -$3.5 million, 8.95% up from the prior year.
- EBIT for Q4 2024 was $1660259127.7 billion at Immuron, up from -$13150.2 in the prior quarter.
- Over five years, EBIT peaked at $1660259127.7 billion in Q4 2024 and troughed at -$13.3 billion in Q4 2021.
- A 5-year average of $276709852.4 billion and a median of -$35260.9 in 2020 define the central range for EBIT.
- Biggest five-year swings in EBIT: plummeted 23116432.23% in 2021 and later surged 1.2625362290076214e+16% in 2024.
- Year by year, EBIT stood at -$57371.6 in 2020, then plummeted by 23116432.23% to -$13.3 billion in 2021, then soared by 100.0% to -$12721.4 in 2022, then fell by 3.37% to -$13150.2 in 2023, then soared by 1.2625362290076212e+16% to $1660259127.7 billion in 2024.
- Business Quant data shows EBIT for IMRN at $1660259127.7 billion in Q4 2024, -$13150.2 in Q4 2023, and -$1.2 million in Q2 2023.